Volume 3, Cancer, presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The DCP3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alternative cancer care packages that are cost-effective and suited to low-resource settings. Main messages from the volume include:
-Quality matters in all aspects of cancer treatment and palliation.
-Cancer registries that track incidence, mortality, and survival paired with systems to capture causes of death are important to understanding the national cancer burden and the effect of interventions over time.
-Effective interventions exist at a range of prices. Adopting ‘resource appropriate’ measures which allow the most effective treatment for the greatest number of people will be advantageous to countries.
-Prioritizing resources toward early stage and curable cancers is likely to have the greatest health impact in low income settings.
-Research prioritization is no longer just a global responsibility.
Providing cancer treatment requires adequate numbers of trained healthcare professionals and infrastructure beyond what is available in most LMICs, especially low income countries. Careful patient monitoring is a requirement of good quality cancer care and this often involves laboratory tests in addition to clinical examination. Even if financing were immediately available to build or expand a cancer control system, reaching capacity will take many years.
© 2015 International Bank for Reconstruction and Development / The World Bank
1818 H Street NW, Washington, DC 20433
Telephone: 202-473-1000; Internet: www.worldbank.org
Some rights reserved
1 2 3 4 18 17 16 15
This work is a product of the staff of The World Bank with external contributions. The findings, interpretations, and conclusions expressed in this work do not necessarily reflect the views of The World Bank, its Board of Executive Directors, or the governments they represent. The World Bank does not guarantee the accuracy of the data included in this work. The boundaries, colors, denominations, and other information shown on any map in this work do not imply any judgment on the part of The World Bank concerning the legal status of any territory or the endorsement or acceptance of such boundaries.
Nothing herein shall constitute or be considered to be a limitation upon or waiver of the privileges and immunities of The World Bank, all of which are specifically reserved.
Rights and Permissions
This work is available under the Creative Commons Attribution 3.0 IGO license (CC BY 3.0 IGO) http://creativecommons.org/licenses/by/3.0/igo. Under the Creative Commons Attribution license, you are free to copy, distribute, transmit, and adapt this work, including for commercial purposes, under the following conditions:
Attribution—Please cite the work as follows: Gelband, H., P. Jha, R. Sankaranarayanan, and S. Horton, editors. 2015. Cancer. Disease Control Priorities, third edition, volume 3. Washington, DC: World Bank. doi:10.1596/978-1-4648-0349-9. License: Creative Commons Attribution CC BY 3.0 IGO
Translations—If you create a translation of this work, please add the following disclaimer along with the attribution: This translation was not created by The World Bank and should not be considered an official World Bank translation. The World Bank shall not be liable for any content or error in this translation.
Adaptations—If you create an adaptation of this work, please add the following disclaimer along with the attribution: This is an adaptation of an original work by The World Bank. Views and opinions expressed in the adaptation are the sole responsibility of the author or authors of the adaptation and are not endorsed by The World Bank.
Third-party content—The World Bank does not necessarily own each component of the content contained within the work. The World Bank therefore does not warrant that the use of any third-party-owned individual component or part contained in the work will not infringe on the rights of those third parties. The risk of claims resulting from such infringement rests solely with you. If you wish to re-use a component of the work, it is your responsibility to determine whether permission is needed for that re-use and to obtain permission from the copyright owner. Examples of components can include, but are not limited to, tables, figures, or images.
All queries on rights and licenses should be addressed to the Publishing and Knowledge Division, The World Bank, 1818 H Street NW, Washington, DC 20433, USA; fax: 202-522-2625; e-mail: gro.knabdlrow@sthgirbup.
View in own window
| Softcover | Hardcover |
|---|
| ISBN (paper): 978-1-4648-0349-9 | ISBN: 978-1-4648-0350-5 |
| ISBN (electronic): 978-1-4648-0369-7 | |
| DOI: 10.1596/978-1-4648-0349-9 | DOI: 10.1596/978-1-4648-0350-5 |
Cover photo: © IAEA Imagebank/Dana Sacchetti/IAEA. Used with permission; further permission required for reuse.
Cover and interior design: Debra Naylor, Naylor Design, Washington, DC
Library of Congress Cataloging-in-Publication Data
Cancer (Gelband)
Cancer / editors, Hellen Gelband, Prabhat Jha, Rengaswamy Sankaranarayanan, Susan Horton.
p.; cm. — (Disease control priorities; volume 3)
Includes bibliographical references and index.
ISBN 978-1-4648-0349-9 (alk. paper) — ISBN 978-1-4648-0350-5 (alk. paper) — ISBN 978-1-4648-0369-7 (electronics)
I. Gelband, Hellen, editor. II. Jha, Prabhat, 1965-, editor. III. Sankaranarayanan, R. (Rengaswamy), 1952-, editor. IV. Horton, Susan, editor. V. World Bank, issuing body. VI. Title. VII. Series: Disease control priorities; v. 3
[DNLM: 1. Neoplasms—economics. 2. Neoplasms—prevention & control. 3. Cost of Illness. 4. Developing Countries. 5. Health Services Research—economics. WA 395]
RC262
362.19699’400681—dc23
2015019371
